These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16157919)

  • 21. beta-N-methylamino-L-alanine induced in vivo retinal cell death.
    Santucci S; Zsürger N; Chabry J
    J Neurochem; 2009 May; 109(3):819-25. PubMed ID: 19309437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros.
    Kisby GE; Ellison M; Spencer PS
    Neurology; 1992 Jul; 42(7):1336-40. PubMed ID: 1620343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida.
    Banack SA; Metcalf JS; Bradley WG; Cox PA
    Toxicon; 2014 Nov; 90():167-73. PubMed ID: 25123936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivo.
    Buenz EJ; Howe CL
    Neurotoxicology; 2007 May; 28(3):702-4. PubMed ID: 17379313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotoxic Non-proteinogenic Amino Acid β-N-Methylamino-L-alanine and Its Role in Biological Systems.
    Popova AA; Koksharova OA
    Biochemistry (Mosc); 2016 Aug; 81(8):794-805. PubMed ID: 27677549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the cycad neurotoxin BMAA in the amyotrophic lateral sclerosis-parkinsonism dementia complex of the western Pacific.
    Duncan MW
    Adv Neurol; 1991; 56():301-10. PubMed ID: 1853765
    [No Abstract]   [Full Text] [Related]  

  • 27. BMAA and Neurodegenerative Illness.
    Cox PA; Kostrzewa RM; Guillemin GJ
    Neurotox Res; 2018 Jan; 33(1):178-183. PubMed ID: 28540663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three phases of research on beta-N-methylamino-L-alanine (BMAA)--a neurotoxic amino acid.
    Nunn PB
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():26-33. PubMed ID: 19929728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.
    Murch SJ; Cox PA; Banack SA
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12228-31. PubMed ID: 15295100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cycad neurotoxic amino acid, beta-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells.
    Brownson DM; Mabry TJ; Leslie SW
    J Ethnopharmacol; 2002 Oct; 82(2-3):159-67. PubMed ID: 12241991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ALS/PDC syndrome of Guam and the cycad hypothesis.
    Bradley WG; Banack SA; Cox PA
    Neurology; 2009 Feb; 72(5):473-4, 476; author reply 475-6. PubMed ID: 19195084
    [No Abstract]   [Full Text] [Related]  

  • 32. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia.
    Sundar PD; Yu CE; Sieh W; Steinbart E; Garruto RM; Oyanagi K; Craig UK; Bird TD; Wijsman EM; Galasko DR; Schellenberg GD
    Hum Mol Genet; 2007 Feb; 16(3):295-306. PubMed ID: 17185385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An explanation for the changes in collagen in sporadic amyotrophic lateral sclerosis.
    Field NC; Caller TA; Stommel EW
    Med Hypotheses; 2011 Oct; 77(4):565-7. PubMed ID: 21745715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD; Banack SA; Cox PA; Weiss JH
    Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-N-methylamino-l-alanine analysis in the brains of patients with Kii ALS/PDC.
    Kokubo Y; Banack SA; Morimoto S; Murayama S; Togashi T; Metcalf JS; Cox PA; Kuzuhara S
    Neurology; 2017 Sep; 89(10):1091-1092. PubMed ID: 28794246
    [No Abstract]   [Full Text] [Related]  

  • 36. beta-Methylamino-L-alanine (BMAA) and amyotrophic lateral sclerosis-parkinsonism dementia of the western Pacific.
    Duncan MW
    Ann N Y Acad Sci; 1992 May; 648():161-8. PubMed ID: 1637043
    [No Abstract]   [Full Text] [Related]  

  • 37. Augmentation and ionic mechanism of effect of beta-N-methylamino-L-alanine in presence of bicarbonate on membrane potential of Retzius nerve cells of the leech Haemopis sanguisuga.
    Lopicic S; Nedeljkov V; Cemerikic D
    Comp Biochem Physiol A Mol Integr Physiol; 2009 Jul; 153(3):284-92. PubMed ID: 19272457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concentrations of Cd, Co, Cu, Fe, Mn, Rb, V, and Zn in formalin-fixed brain tissue in amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam determined by High-resolution ICP-MS.
    Gellein K; Garruto RM; Syversen T; Sjøbakk TE; Flaten TP
    Biol Trace Elem Res; 2003; 96(1-3):39-60. PubMed ID: 14716085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice.
    Cruz-Aguado R; Winkler D; Shaw CA
    Pharmacol Biochem Behav; 2006 Jun; 84(2):294-9. PubMed ID: 16808967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of the putative neurotoxin 2-amino-3-(methylamino)propanoic acid (BMAA) in cycadales: analysis of the seeds of some members of the family Cycadaceae.
    Duncan MW; Kopin IJ; Crowley JS; Jones SM; Markey SP
    J Anal Toxicol; 1989; 13(4):suppl A-G. PubMed ID: 2490746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.